Patent details

Basic Information

Publication number:

EP3654989

PCT Application Number:

GB2018051801

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP187395934

PCT Publication Number:

WO2019016505

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF CLADRIBINE FOR TREATING AUTOIMMUNE NEUROMUSCULAR DISEASE

French Title of Invention:

UTILISATION DE CLADRIBINE POUR LE TRAITEMENT D'UNE MALADIE NEUROMUSCULAIRE AUTO-IMMUNE

German Title of Invention:

VERWENDUNG VON CLADRIBIN ZUR BEHANDLUNG AUTOIMMUNER NEUROMUSKULÄRER ERKRANKUNGEN

SPC Number:

Dates

Filing date:

28/06/2018

Grant date:

03/01/2024

EP Publication Date:

27/05/2020

PCT Publication Date:

24/01/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/01/2024

EP B1 Publication Date:

03/01/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

28/06/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/12/2023

 

 

Name:

Chord Therapeutics SA

Address:

c/o ARES TRADING SA Terre Bonne Business Park Route de Crassier 1, 1262 Eysins, Switzerland (CH)

Inventor

Name:

REJDAK, Konrad

Address:

Poland (PL)

Priority

Priority Number:

201711800

Priority Date:

21/07/2017

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

A61K 31/7076; A61P 21/04; A61P 37/06;

Publication

European Patent Bulletin

Issue number:

202401

Publication date:

03/01/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/06/2026

Annual Fee Number:

9

Annual Fee Amount:

115 Euro

Expected Payer:

Last Annual Fee Payment Date:

23/05/2025

Last Annual Fee Paid Number:

8

Last Annual Fee Paid Amount:

99 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages